ICAM1 and lung carcinoma: In vitro, investigations using lung cancer cell lines A549, H358, and H460 showed that CBD upregulated the antimetastatic protein ICAM-1, which is hypothesized to reduce tumor development through an immunosurveillance mechanism (Benedicto et al., 2017).